Skip to main content

Table 1 Results of the univariate and multivariable (adjusted) analysis of predictors for severe dengue in a cohort of 340 patients presenting to hospitals in Honduras

From: A retrospective cohort study to predict severe dengue in Honduran patients

  Cases
N = 34
Non-cases
N = 286
Odds ratio (95% CI) Adjusted Odds ratio (95% CI)
Ascites 4 (11.76%) 7 (2.44%) 5.31 (1.47 to 19.2) 7.29 (1.85 to 28.7)
Headache 26 (76.47%) 252 (88.11%) 0.44 (0.18 to 1.05) 0.38 (0.15 to 0.95)
Skin rash 9 (26.47%) 113 (39.51%) 0.55 (0.25 to 1.22)  
Occular pain 23 (67.64%) 221 (77.27%) 0.62 (0.28 to 1.32)  
Petechiae 4 (11.76%) 95 (33.21%) 0.27 (0.09 to 0.78) 0.24 (0.08 to 0.73)
Ecchymosis 0(1.47%) 35 (12.4%) 0.10(0.006 to 1.76)  
Sex (male) 21 (61.76%) 156 (54.54%) 1.34 (0.65 to 2.80)  
Age (≥12 years) 20 (58.82%) 173 (60.49%) 0.93 (0.45 to 1.96)  
Symptom onset to admission (≤ 3 days) 5 (14.709%) 64 (22.38%) 0.60 (0.20 to 1.53)  
Platelets at admission (≤50,000) 24 (70.58%) 128 (44.76%) 2.95 (1.38 to 6.74) 2.9 (1.42 to 6.42)
Platelets at 48 h (≤100,000) 1 (2.94%) 31 (10.84%) 0.25 (0.01 to 1.39)  
Fever 34 (100%) 282 (98.6%) 0.99(0.97 to 1.00)  
Arthralgia 26 (76.5%) 220 (77.0%) 0.97 (0.42 to 2.25)  
Myalgia 29 (85.3%) 251(87.8%) 0.81 (0.30 to 2.22)  
Anorexia 27 (79.4%) 233 (81.4%) 0.88 (0.36 to 2.12)  
Vomiting 15 (44.1%) 98 (34.3%) 1.50 (0.74 to 3.11)  
Hematemesis 1 (2.9%) 20(7.0%) 0.40 (0.05 to 3.10)  
Melena 2 (5.9%) 7 (2.4%) 2.50 (0.50 to 12.50)  
Tourniquet test 3 (8.8%) 15 (5.2%) 1.75 (0.48 to 6.38)  
Epistaxis 7 (20.6%) 43 (15.0%) 1.46(0.60 to 3.58)  
Gingival bleeding 3 (8.8%) 16 (5.6%) 1.63 (0.45 to 5.90)  
Hematuria 1 (2.9%) 9 (3.2%) 0.93 (0.11 to 7.60)  
Methrorragia 1 (2.9%) 8(2.8%) 1.05 (0.13 to 8.69)  
Abdominal Pain 16 (47.0%) 128 (4.5%) 1.10 (0.54 to 2.29)  
Cold extremity 10 (29.4%) 97 (33.9%) 0.81 (0.37 to 1.77)  
Sweating 14 (41.2%) 137 (47.9%) 0.76 (0.37 to 1.60)  
Pallor (skin) 15 (44.1%) 118 (41.3%) 1.12 (0.55 to 2.30)  
Pericardium effusion 0 (0%) 4 (1.4%) 0.98 (0.97 to 1.00)  
Pleural effusion 2 (5.9%) 8 (2.8%) 2.20 (0.44 to 10.70)